1. Suputtamongkol Y, Hall AJ, Dance DA, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol. 1994; 23(5):1082–1090. PMID:
7860160.
Article
2. Whitmore A, Krishnaswami CS. An account of the discovery of a hitherto undescribed infectious disease among the population of Rangoon. Ind Med Gaz. 1912; 47:262–267.
3. Cheng AC, Hanna JN, Norton R, et al. Melioidosis in northern Australia, 2001-02. Commun Dis Intell Q Rep. 2003; 27(2):272–277. PMID:
12926743.
4. Leelarasamee A, Trakulsomboon S, Kusum M, Dejsirilert S. Isolation rates of Burkholderia pseudomallei among the four regions in Thailand. Southeast Asian J Trop Med Public Health. 1997; 28(1):107–113.
5. Raghavan KR, Shenoi RP, Zaer F, Aiyer R, Ramamoorthy P, Mehta MN. Melioidosis in India. Indian Pediatr. 1991; 28(2):184–188. PMID:
2055637.
6. John TJ, Jesudason MV, Lalitha MK, et al. Melioidosis in India: the tip of the iceberg? Indian J Med Res. 1996; 103:62–65. PMID:
8926030.
7. Punyagupta S. Melioidosis: review of 686 cases and presentation of a new clinical classification. In : Punyagupta S, Sirisanthana T, Stapatayavong B, editors. Melioidosis. Bangkok, Thailand: Bangkok Medical;1989. p. 217–229.
8. Chaowagul W, White NJ, Dance DA, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989; 159(5):890–899. PMID:
2708842.
Article
9. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012; 367(11):1035–1044. PMID:
22970946.
Article
10. Chrispal A, Rajan SJ, Sathyendra S. The clinical profile and predictors of mortality in patients with melioidosis in South India. Trop Doct. 2010; 40(1):36–38. PMID:
19850605.
Article
11. Mukhopadhyay C, Dey A, Sugandhi Rao P, Pandey V, Sripathi Rao P. Aetiology and management of chronic granulomatous osteomyelitis: look before you leap. Singapore Med J. 2007; 48(2):e40–e42. PMID:
17304376.
12. Pandey V, Rao SP, Rao S, Acharya KK, Chhabra SS. Burkholderia pseudomallei musculoskeletal infections (melioidosis) in India. Indian J Orthop. 2010; 44(2):216–220. PMID:
20419012.
Article
13. Ng WM, Kwan MK, Merican AM. Melioidotic osteomyelitis treated with antibiotic-calcium hydroxyapatite composite: case report with four-year follow-up. Singapore Med J. 2006; 47(1):71–74. PMID:
16397726.
14. Subhadrabandhu T, Prichasuk S, Sathapatayavongs B. Localised melioidotic osteomyelitis. J Bone Joint Surg Br. 1995; 77(3):445–449. PMID:
7744934.
Article
15. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 1989; 2(8665):697–701. PMID:
2570956.
Article
16. Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014; 383(9919):807–814. PMID:
24284287.
Article
17. Cheng AC, Limmathurotsakul D, Chierakul W, et al. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007; 45(3):308–314. PMID:
17599307.
Article
18. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis. 2000; 31(4):981–986. PMID:
11049780.
Article